Suppr超能文献

老年人慢性阻塞性肺疾病。功能障碍的一个可逆原因。

COPD in the elderly. A reversible cause of functional impairment.

作者信息

Chang J T, Moran M B, Cugell D W, Webster J R

机构信息

Northwestern University Medical School, Chicago, IL, USA.

出版信息

Chest. 1995 Sep;108(3):736-40. doi: 10.1378/chest.108.3.736.

Abstract

OBJECTIVES

To determine the frequency of referral of patients age 69 years and older to the pulmonary function laboratory at a tertiary-care hospital for airflow limitation studies; to determine the point prevalence of a significant reversible component in patients with COPD as an age-related function; and to determine the proportion of patients who were prescribed bronchodilators following a pulmonary function test (PFT) demonstrating significant reversibility.

DESIGN

A retrospective review of pulmonary function tests of patients 69 years and older within calendar year 1990 was performed. Chart review of those showing significant reversibility to bronchodilators during a PFT was performed to determine level of follow-up.

SETTING

Referral-based pulmonary division in a tertiary-care hospital.

PATIENTS

Men and women 69 years and older who had interpretable PFTs at Northwestern Memorial Hospital (NMH) during the calendar year 1990 (n = 405). Patients whose PFTs were uninterpretable due to poor effort (n = 10) were excluded from the study.

INTERVENTIONS

No specific interventions were performed as a part of the study. Referring physicians may have requested a PFT with postbronchodilator (albuterol by nebulizer) testing and may have subsequently prescribed bronchodilators for their patients.

MEASUREMENTS

We studied the effect of age, gender, smoking history, and degree of airflow obstruction on changes in spirometry values and reversibility status after bronchodilator (if applicable) as determined by a PFT.

MAIN RESULTS

Of the 405 consecutive elderly patients studied, 193 (47.7%) received bronchodilators and 60 (31.1%) of these patients had significant improvement as judged by the criteria listed in the Methods section. The improvement occurred equally across all age groups (p > 0.05) and the percent responding to bronchodilators increased as the degree of obstruction increased (p < 0.001). Those who had never smoked were twice as likely to respond than were current or former smokers; men were more likely to respond than women. Most patients (84%) who responded were subsequently prescribed bronchodilators.

CONCLUSIONS

Responses to inhaled bronchodilators occur at all ages. Older patients showed greater reversibility as the degree of obstruction increased, while a smoking history reduced the likelihood of a bronchodilator response. COPD in the elderly may differ from the traditional form of the disease.

摘要

目的

确定69岁及以上患者被转诊至一家三级医疗医院的肺功能实验室进行气流受限研究的频率;确定慢性阻塞性肺疾病(COPD)患者中显著可逆成分的时点患病率与年龄的关系;确定在肺功能测试(PFT)显示显著可逆性后被开具支气管扩张剂的患者比例。

设计

对1990日历年69岁及以上患者的肺功能测试进行回顾性研究。对那些在PFT期间对支气管扩张剂显示出显著可逆性的患者进行病历审查,以确定随访情况。

地点

一家三级医疗医院中基于转诊的肺科。

患者

1990日历年在西北纪念医院(NMH)进行了可解释的PFT的69岁及以上男性和女性(n = 405)。因配合不佳导致PFT无法解释的患者(n = 10)被排除在研究之外。

干预措施

作为研究的一部分,未进行特定干预。转诊医生可能要求进行支气管扩张剂后(通过雾化器使用沙丁胺醇)的PFT测试,并可能随后为其患者开具支气管扩张剂。

测量指标

我们研究了年龄、性别、吸烟史和气流阻塞程度对肺活量测定值变化以及支气管扩张剂(如适用)后可逆性状态的影响,这些由PFT确定。

主要结果

在研究的405例连续老年患者中,193例(47.7%)接受了支气管扩张剂治疗,其中60例(31.1%)患者根据方法部分列出的标准判断有显著改善。各年龄组的改善情况相同(p > 0.05),对支气管扩张剂有反应的百分比随阻塞程度增加而增加(p < 0.001)。从未吸烟的患者对支气管扩张剂有反应的可能性是当前或既往吸烟者的两倍;男性比女性更有可能有反应。大多数有反应的患者(84%)随后被开具了支气管扩张剂。

结论

各年龄段对吸入性支气管扩张剂均有反应。老年患者随着阻塞程度增加显示出更大的可逆性,而吸烟史会降低支气管扩张剂反应的可能性。老年COPD可能与该疾病的传统形式有所不同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验